查看購物車
  • Simplified Chinese
  • Japanese
乾眼症治療市場（2025）：全球分析（2024-2030）
市場調查報告書
商品編碼
1876881

乾眼症治療市場（2025）：全球分析（2024-2030）

2025 Dry Eye Pharmaceuticals Market Report: Global Analysis for 2024 to 2030
出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

"乾眼症治療市場（2025）報告" 對全球乾眼症藥物市場進行了全面分析，檢視了該疾病的盛行率、診斷和治療現狀。本報告深入涵蓋了人工淚液、抗發炎眼藥水、殺蟎劑、淚液蒸發抑制劑、黏蛋白分泌促進劑以及其他處方藥和非處方藥，並對2030年之前的區域需求、銷售額和市場表現進行了詳細預測。

本報告基於數據，對乾眼症市場的現狀和成長潛力進行了評估，重點關注新產品開發、新興給藥方式和不斷擴展的藥物研發管線。報告提供了七個主要區域的全球和區域預測，涵蓋了競爭格局、監管差異和治療趨勢。報告中也介紹了23家主要公司及其在乾眼症市場的策略定位。

目錄：

"2025年乾眼症治療市場報告" 評估了用於治療乾眼症的處方藥和非處方藥市場的發展趨勢。該報告結合了流行病學數據、疾病特徵和五年市場預測，概述了眼科領域中成長最快的類別之一的未來機會。

本報告涵蓋的主題包括：

  • 乾眼症概述： 正常淚液功能解剖、症狀、危險因子、診斷標準和 DEWS 分類
  • 盛行率和風險分析： 美國、西歐、日本、中國、印度、拉丁美洲和其他市場的區域估計和風險概況
  • 診斷與治療趨勢： 診斷方法、區域實踐差異與嚴重程度區隔
  • 治療途徑和產品區隔： 潤滑劑、止汗劑、發炎和緩釋療法分析
  • 全球和區域市場預測： 單位需求、收入預測、依產品類型和公司劃分的市場佔有率以及消費趨勢2030
  • 藥物研發管線分析深入分析30餘種在研化合物及新興藥物遞送技術
  • 主要競爭對手概況深入分析23家領先的乾眼症治療藥物生產商，包括產品組合、策略及前景
簡介目錄

The "2025 Dry Eye Pharmaceuticals Market Report" provides a comprehensive analysis of the global market for dry eye therapeutics, examining the disease's prevalence, diagnosis, and treatment landscape. The report provides in-depth coverage of artificial tears, anti-inflammatory drops, miticides, tear evaporation inhibitors, mucin secretagogues, and other prescription and over-the-counter products-with detailed forecasts of unit demand, sales revenue, and market performance by region through 2030.

The report offers a data-driven assessment of the current dry eye marketplace and its growth potential, highlighting new product development, emerging drug-delivery methods, and the expanding pharmaceutical pipeline. Global and regional forecasts are presented for seven major regions, with coverage of competitive dynamics, regulatory differences, and therapeutic trends. Profiles are provided for 23 leading companies and their strategic positioning within the dry eye market.

Contents:

The "2025 Dry Eye Pharmaceuticals Market Report" evaluates the evolving market for prescription and over-the-counter therapies used in the management of dry eye disease. The report combines epidemiological data, disease characterization, and five-year market projections to outline future opportunities in one of ophthalmology's fastest-growing categories.

The following topics are covered in the report:

  • Comprehensive overview of dry eye disease: anatomy of normal tear function, symptoms, risk factors, diagnostic criteria, and DEWS classification
  • Prevalence and risk analysis: regional estimates and risk profiles for the US, Western Europe, Japan, China, India, Latin America, and other global markets
  • Diagnosis and care trends: approaches to diagnosis, regional practice variations, and severity segmentation
  • Treatment pathways and product segmentation: analysis of lubricants, anti-inflammatories, and sustained-release therapeutics
  • Global and regional market forecasts: unit demand, revenue forecasts, market share by product type and company, and consumption trends through 2030
  • Pharmaceutical pipeline analysis: detailed review of more than 30 investigational compounds and emerging drug-delivery technologies
  • Profiles of major competitors: in-depth profiles of 23 leading dry eye pharmaceutical manufacturers, including their portfolios, strategies, and outlook